|
[1]
|
Solomon, B., Young, R.J. and Rischin, D. (2018) Head and Neck Squamous Cell Carcinoma: Genomics and Emerging Biomarkers for Immunomodulatory Cancer Treatments. Seminars in Cancer Biology, 52, 228-240. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Johnson, D.E., et al. (2020) Head and Neck Squamous Cell Carcinoma. Nature Reviews Disease Primers, 6, Article No. 92. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Jou, A. And, J. (2017) Hess, Epidemiology and Molecular Bi-ology of Head and Neck Cancer. Oncology Research and Treatment, 40, 328-332. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Alsahafi, E., et al. (2019) Clinical Update on Head and Neck Cancer: Mo-lecular Biology and Ongoing Challenges. Cell Death & Disease, 10, Article No. 540. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
The Cancer Genome Atlas Network (2015) Comprehensive Ge-nomic Characterization of Head and Neck Squamous Cell Carcinomas. Nature, 517, 576-582. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Leemans, C.R., Snijders, P.J.F. and Brakenhoff, R.H. (2018) The Molec-ular Landscape of Head and Neck Cancer. Nature Reviews Cancer, 18, 269-282. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Resteghini, C., et al. (2018) Big Data in Head and Neck Cancer. Current Treatment Options in Oncology, 19, Article No. 62. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Csizmadia, T. and Low, P. (2020) The Role of Deubiquitinating Enzymes in the Various Forms of Autophagy. International Journal of Molecular Sciences, 21, Article No. 4196. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Collins, G.A. and Goldberg, A.L. (2017) The Logic of the 26S Proteasome. Cell, 169, 792-806. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Komander, D., Clague, M.J. and Urbe, S. (2009) Breaking the Chains: Structure and Function of the Deubiquitinases. Nature Reviews Molecular Cell Biology, 10, 550-563. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Mevissen, T.E.T. and Komander, D. (2017) Mechanisms of Deubiquitinase Specificity and Regulation. Annual Review of Biochemistry, 86, 159-192. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Abdul Rehman, S.A., et al. (2016) MINDY-1 Is a Member of An Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes. Molecular Cell, 63, 146-155. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Reyes-Turcu, F.E., K.H. Ventii, and Wil-kinson, K.D. (2009) Regulation and Cellular Roles of Ubiquitin-Specific Deubiquitinating Enzymes. Annual Review of Biochemistry, 78, 363-397. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Nijman, S.M., et al. (2005) A Genomic and Functional Inventory of Deubiquitinating Enzymes. Cell, 123, 773-786. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Hu, M., Li, P., Li, M., Li, W., Yao, T., Wu, J.W., Gu, W., Cohen, R.E. and Shi, Y. (2002) Crystal Structure of a UBP-Family Deubiquitinating Enzyme in Isolation and in Complex with Ubiquitin Aldehyde. Cell, 111, 1041-1054. [Google Scholar] [CrossRef]
|
|
[16]
|
Qu, Q., et al. (2015) USP2 Promotes Cell Migration and Invasion in Triple Negative Breast Cancer Cell Lines. Tumor Biology, 36, 5415-5423. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Graner, E., Tang, D., Rossi, S., Baron, A., Migita, T., Weinstein, L.J., Lechpammer, M., Huesken, D., Zimmermann, J., Signoretti, S. and Loda, M. (2004) The Isopeptidase USP2a Reg-ulates the Stability of Fatty Acid Synthase in Prostate Cancer. Cancer Cell, 5, 253-261. [Google Scholar] [CrossRef]
|
|
[18]
|
Boustani, M.R., et al. (2016) Overexpression of Ubiqui-tin-Specific Protease 2a (USP2a) and Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) in Human Gliomas. Journal of the Neurological Sciences, 363, 249-252. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Turnbull, A.P., et al. (2017) Molecular Basis of USP7 Inhibition by Selective Small-Molecule Inhibitors. Nature, 550, 481-486. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Wang, Z., et al. (2019) USP7: Novel Drug Target in Cancer Therapy. Frontiers in Pharmacology, 10, Article No. 427. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Pannem, R.R., et al. (2014) CYLD Controls C-MYC Expression through the JNK-Dependent Signaling Pathway in Hepatocellular Carcinoma. Carcinogenesis, 35, 461-468. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Massoumi, R., et al. (2006) Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling. Cell, 125, 665-677. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Zhang, J., et al. (2006) Impaired Regulation of NF-κB and Increased Susceptibility to Colitis-Associated Tumorigenesis in CYLD-Deficient Mice. Journal of Clinical Investigation, 116, 3042-3049. [Google Scholar] [CrossRef]
|
|
[24]
|
Chen, Y., et al. (2018) Reduced Expression of Deubiquitinase USP33 Is Associated with Tumor Progression and Poor Prognosis of Gastric Adenocarcinoma. Medical Science Monitor, 24, CLR3496-3505. [Google Scholar] [CrossRef]
|
|
[25]
|
Melo-Cardenas, J., Xu, Y., Wei, J., et al. (2018) USP22 Deficiency Leads to Myeloid Leukemia upon Oncogenic Kras Activation through a PU 1-Dependent Mechanism. Blood, 132, 423-434. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Koutelou, E., Wang, L., Schibler, A.C., et al. (2019) USP22 Controls Multiple Signaling Pathways That Are Essential for Vasculature Formation in the Mouse Placenta. Development, 146, Dev174037. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Lai, K.P., Chen, J. and Tse, W.K.F. (2020) Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy. International Journal of Molecular Sciences, 21, Article No. 2548. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Liu, T., Liu, J., Chen, Q., Jin, S., Mi, S., Shao, W., Kudo, Y., Zeng, S. and Qi, G. (2019) Expression of USP22 and the Chromosomal Passenger Complex Is An Indicator of Malig-nant Progression in Oral Squamous Cell Carcinoma. Oncology Letters, 17, 2040-2046. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Dou, Y., Lin, J., Shu, H., Jiang, N. (2014) Role of Ubiquitin-Specific Peptidase 22 in Carcinogenesis of Human Pharyngeal Squamous Cell Carcinoma. Molecular Medicine Reports, 10, 2973-2978. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
莫文法. 鼻咽癌组织中USP22和C-Myc的表达及临床意义[J]. 继续医学教育, 2019, 33(8): 130-132.
|
|
[31]
|
Zhuang, Y.J., Liao, Z.W., Yu, H.W., Song, X.L., Liu, Y., Shi, X.Y., Lin, X.D. and Zhou, T.C. (2015) ShRNA-Mediated Silencing of the Ubiquitin-Specific Protease 22 Gene Restrained Cell Progression and Affected the Akt Pathway in Nasopharyngeal Carcinoma. Cancer Biology & Therapy, 16, 88-96. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
李丽娟, 温树信, 王斌全, 高伟, 张文, 孟晓敏, 等. 肿瘤干细胞标记物USP22蛋白在喉鳞状细胞癌中的表达及预后分析[J]. 中华耳鼻咽喉头颈外科杂志, 2014, 49(6): 479-482.
|
|
[33]
|
Harris, D.R., Mims, A. and Bunz, F. (2012) Genetic Disruption of USP9X Sensitizes Colorectal Cancer Cells to 5-Fluorouracil. Cancer Biology & Therapy, 13, 1319-1324. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Cox, J.L., Wilder, P.J., Wuebben, E.L., Ouellette, M.M., Hollingsworth, M.A. and Rizzino, A. (2014) Context-Dependent Function of the Deubiquitinating Enzyme USP9X in Pancreatic Ductal Adenocarcinoma. Cancer Biology & Therapy, 15, 1042-1052. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Liu, H., Chen, W., Liang, C., et al. (2015) WP1130 Increases Doxorubicin Sensitivity in Hepatocellular Carcinoma Cells through Usp9x-Dependent P53 Degradation. Cancer Letters, 361, 218-225. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Peng, J., Hu, Q., Liu, W., et al. (2013) USP9X Expression Cor-relates with Tumor Progression and Poor Prognosis in Esophageal Squamous Cell Carcinoma. Diagnostic Pathology, 8, Article No. 177. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Perez-Mancera, P.A., Rust, A.G., Van Der Weyden, L., et al. (2012) The Deubiquitinase USP9X Suppresses Pancreatic Ductal Adenocarcinoma. Nature, 486, 266-270. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Wang, M.L., Panasyuk, G., Gwalter, J., Nemazanyy, I., Fenton, T., Filo-nenko, V. and Gout, I. (2008) Regulation of Ribosomal Protein S6 Kinases by Ubiquitination. Biochemical and Biophys-ical Research Communications, 369, 382-387. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Panasyuk, G., Nemazanyy, I., Filonenko, V. and Gout, I. (2008) Ribosomal Protein S6 Kinase 1 Interacts with and Is Ubiquitinated by Ubiquitin Ligase ROC1. Biochemical and Bio-physical Research Communications, 369, 339-343. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Nanayakkara, D.M., Nguyen, M.N. and Wood, S.A. (2016) Deubiquitylating Enzyme, USP9X, Regulates Proliferation of Cells of Head and Neck Cancer Lines. Cell Proliferation, 49, 494-502. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Khan, O.M., Carvalho, J., Spencer-Dene, B., et al. (2018) The Deubiquitinase USP9X Regulates FBW7 Stability and Suppresses Colorectal Cancer. Journal of Clinical Investigation, 128, 1326-1337. [Google Scholar] [CrossRef]
|
|
[42]
|
冯燚源, 杨晶, 张雪, 李珊珊, 李源泉, 杨洪斌. USP9X与MCL-1在鼻咽癌中表达及预后分析[J]. 中国老年学杂志, 2022, 42(7): 1584-1587.
|
|
[43]
|
Everett, R.D., Meredith, M., Orr, A., Cross, A., Kathoria, M. and Parkinson, J. (1997) A Novel Ubiquitin-Specific Protease Is Dynamically As-sociated with the PML Nuclear Domain and Binds to a Herpesvirus Regulatory Protein. The EMBO Journal, 16, 1519-1530. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Zhou, J., Wang, J., Chen, C., Yuan, H., Wen, X. and Sun, H. (2018) USP7: Target Validation and Drug Discovery for Cancer Therapy. Medicinal Chemistry, 14, 3-18. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
周芨, 邓世山, 刘海. USP7在喉癌组织中的表达及其临床意义[J]. 中国耳鼻咽喉颅底外科杂志, 2015, 21(1): 27-30.
|
|
[46]
|
Jing, Y., Yang, Y., Hao, F., et al. (2018) Higher Ki67 Expression in Fibroblast Like Cells at Invasive Front Indicates Better Clinical Outcomes in Oral Squamous Cell Carcinoma Patients. Bioscience Reports, 38, BSR20181271. [Google Scholar] [CrossRef]
|
|
[47]
|
Celentano, A., Yap, T., Paolini, R., Yiannis, C., Mirams, M., Koo, K., McCullough, M. and Cirillo, N. (2021) Inhibition of Matrix Metalloproteinase-2 Modulates Malignant Behaviour of Oral Squamous Cell Carcinoma Cells. Journal of Oral Pathology & Medicine, 50, 323-332. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Mărgăritescu, C., Pirici, D., Stîngă, A., Simionescu, C., Raica, M., Mogo-antă, L., Stepan, A. and Ribatti, D. (2010) VEGF Expression and Angiogenesis in Oral Squamous Cell Carcinoma: An Immunohistochemical and Morphometric Study. Clinical and Experimental Medicine, 10, 209-214. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Yang, X., Jin, J., Yang, J., Zhou, L., Mi, S. and Qi, G. (2021) Expression of Ubiquitin-Specific Protease 7 in Oral Squamous Cell Carcinoma Promotes Tumor Cell Proliferation and Invasion. Genetics and Molecular Biology, 44, e20210058. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Hwang, C.F., Huang, H.Y., Chen, C.H., Chien, C.Y., Hsu, Y.C., Li, C.F. and Fang, F.M. (2012) Enhancer of Zeste Homolog 2 Overexpression in Nasopharyngeal Carcinoma: An Independent Poor Prognosticator That Enhances Cell Growth. International Journal of Radiation Oncology, Biology, Physics, 82, 597-604. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Shiogama, S., Yoshiba, S., Soga, D., Motohashi, H. and Shintani, S. (2013) Aberrant Expression of EZH2 Is Associated with Pathological Findings and P53 Alteration. Anticancer Re-search, 33, 4309-4317.
|
|
[52]
|
Zhang, M.J., Chen, D.S., Li, H., Liu, W.W., Han, G.Y. and Han, Y.F. (2019) Clinical Sig-nificance of USP7 and EZH2 in Predicting Prognosis of Laryngeal Squamous Cell Carcinoma and Their Possible Func-tional Mechanism. International Journal of Clinical and Experimental Pathology, 12, 2184-2194.
|
|
[53]
|
Scortegagna, M., Subtil, T., Qi, J., Kim, H., Zhao, W., Gu, W., Kluger, H. and Ronai, Z.A. (2011) USP13 Enzyme Regulates Siah2 Ligase Stability and Activity Via Noncatalytic Ubiquitin-Binding Domains. Journal of Biological Chemistry, 286, 27333-27341. [Google Scholar] [CrossRef]
|
|
[54]
|
陶守松, 刘凯, 李亚婷, 王婷, 葛志强, 詹轶群, 尹荣华, 任广明, 杨晓明. 去泛素化酶USP13在癌症中的研究进展[J]. 军事医学, 2021, 45(1): 76-80.
|
|
[55]
|
Zhang, J., Zhang, P., Wei, Y., et al. (2013) Deubiquitylation and Stabilization of PTEN by USP13. Nature Cell Biology, 15, 1486-1494. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Man, X., Piao, C., Lin, X., et al. (2019) USP13 Functions as a Tumor Sup-pressor by Blocking the NF-κB-Mediated PTEN Downregulation in Human Bladder Cancer. Journal of Experimental & Clinical Cancer Research, 38, Article No. 259. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Han, C., Yang, L., Choi, H.H., et al. (2016) Amplification of USP13 Drives Ovarian Cancer Metabolism. Nature Communications, 7, Arti-cle No. 13525. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Wu, Y., Zhang, Y., Liu, C., et al. (2019) Amplification of USP13 Drives Non-Small Cell Lung Cancer Progression Mediated by AKT/MAPK Signaling. Biomedicine & Phar-macotherapy, 114, Article ID: 108831. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
屈直. USP13在口腔鳞癌中的作用及其分子机制[D]: [博士学位论文]. 沈阳: 中国医科大学, 2020.
|
|
[60]
|
Goidts, V., Szamalek, J.M., Hameister, H., et al. (2004) Segmental Du-plication Associated with the Human-Specific Inversion of Chromosome 18: A Further Example of the Impact of Seg-mental Duplications on Karyotype and Genome Evolution in Primates. Human Genetics, 115, 116-122. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Chen, X., Wu, J., Chen, Y., Ye, D., Lei, H., Xu, H., Yang, L., Wu, Y. and Gu, W. (2016) Ubiquitin-Specific Protease 14 Regulates Cell Proliferation and Apoptosis in Oral Squamous Cell Carcinoma. The International Journal of Biochemistry & Cell Biology, 79, 350-359. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Jiang, L., Sun, Y., Wang, J., He, Q., Chen, X., Lan, X., Chen, J., Dou, Q.P., Shi, X. and Liu, J. (2019) Proteasomal Cysteine Deubiquitinase Inhibitor B-AP15 Suppresses Migration and Induces Apoptosis in Diffuse Large B Cell Lymphoma. Journal of Experimental & Clinical Cancer Research, 38, Article No. 453. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Zhao, B., Schlesiger, C., Masucci, M.G. and Lindsten, K. (2009) The Ubiquitin Specific Protease 4 (USP4) Is a New Player in the Wnt Signalling Pathway. Journal of Cellular and Mo-lecular Medicine, 13, 1886-1895. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Klaus, A. and Birchmeier, W. (2008) Wnt Signalling and Its Impact on Development and Cancer. Nature Reviews Cancer, 8, 387-398. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Hou, X., Wang, L., Zhang, L., Pan, X. and Zhao, W. (2013) Ubiqui-tin-Specific Protease 4 Promotes TNF-α-Induced Apoptosis by Deubiquitination of RIP1 in Head and Neck Squamous Cell Carcinoma. FEBS Letters, 587, 311-316. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Xiao, N., Li, H., Luo, J., et al. (2012) Ubiquitin-Specific Prote-ase 4 (USP4) Targets TRAF2 and TRAF6 for Deubiquitination and Inhibits TNF-Induced Cancer Cell Migration. Bio-chemical Journal, 441, 979-986. [Google Scholar] [CrossRef]
|
|
[67]
|
Wang, X., Liu, Z., Zhang, L., et al. (2018) Targeting Deubiquitinase USP28 for Cancer Therapy. Cell Death & Disease, 9, Article No. 186. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Prieto-Garcia, C., Hartmann, O., Reissland, M., et al. (2020) Maintaining Protein Stability of ∆Np63 Via USP28 Is Required by Squamous Cancer Cells. EMBO Molecular Medicine, 12, e11101. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Zhang, D., Zaugg, K., Mak, T.W. and Elledge, S.J. (2006) A Role for the Deubiquitinating Enzyme USP28 in Control of the DNA-Damage Response. Cell, 126, 529-542. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Bassermann, F., Frescas, D., Guardavaccaro, D., Busino, L., Peschiaroli, A. and Pagano, M. (2008) The Cdc14B-Cdh1-Plk1 Axis Controls the G2 DNA-Damage-Response Check-point. Cell, 134, 256-267. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Benevolo, M., Musio, A., Vocaturo, A., et al. (2012) Claspin as a Biomarker of Human Papillomavirus-Related High Grade Lesions of Uterine Cervix. Journal of Translational Medicine, 10, Article No. 132. [Google Scholar] [CrossRef] [PubMed]
|